Q2 2020 Sunesis Pharmaceuticals Inc Earnings Call Transcript

Aug 11, 2020 / 08:30PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Second Quarter 2020 Sunesis Pharmaceuticals Earnings Conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I will now hand the conference over to your speaker today, Par Hyare, Senior Vice President, Commercial. Please go ahead.

Parvinder S. Hyare - Sunesis Pharmaceuticals, Inc. - SVP of Commercial

Welcome, everyone, and thank you for joining us. With me today are Dayton Misfeldt, Interim CEO; and Judy Fox, Chief Scientific Officer, EVP, Research and Development. Dayton will review recent corporate events and provide a brief financial overview of the second quarter of 2020. We will then open the call for questions for which we will all be available.

Before we begin, let me remind you that during today's conference call, we will be making forward-looking statements that represent the company's intentions, expectations or beliefs concerning future events. These forward-looking statements are qualified by important

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot